The current price of MDWD is $14.25 — it has increased by 6.90% since the previous close. Data as of Nov 6, 2026.
MDWD is up 5.56% over the past week, up 10.89% over the past month and down 18.85% over the past year. The price is below its 200-day moving average of $15.15.
Analysts' average 12-month price target for MDWD is $28.50, which implies 100.00% upside from the current price. Individual estimates range from $27.00 to $30.00.
Of the 6 analysts covering MediWound Ltd., 1 rates it a strong buy and 5 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
MediWound Ltd. has a market capitalization of $183.97M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, MediWound Ltd. posted a loss of $0.77 per share against an estimate of -$0.7617, missing expectations by 1.09%. Upcoming reports are listed in the earnings calendar.
MediWound Ltd. reported revenue of $3.09M in its most recent quarter, which has decreased by 45.83% compared with the same quarter a year earlier. Analysts had expected $2.59M.
MediWound Ltd. has not paid any dividends over the past year.
Companies most comparable to MediWound Ltd. include SELLAS Life Sciences Group, Inc., Genfit S.A., Eupraxia Pharmaceuticals Inc., Orchestra BioMed Holdings, Inc. and Cartesian Therapeutics, Inc.
In the latest trading session MDWD moved between $13.34 and $14.28, a range of 6.63% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of MediWound Ltd. shows a buy rating today and a neutral rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for MediWound Ltd. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks MDWD has traded between $11.80 and $19.70. The current price is 27.66% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.